Somatic genetic alterations (LOH) in benign, borderline and invasive ovarian tumours: Intratumoral molecular heterogeneity

被引:0
|
作者
Zborovskaya, I
Gasparian, A
Karseladze, A
Elcheva, T
Trofimova, E
Driouch, K
Trassard, M
Tatosyan, A
Lidereau, R [1 ]
机构
[1] Ctr Rene Huguenin, F-92211 St Cloud, France
[2] Russian Acad Med Sci, Canc Res Ctr, Lab Oncogene Regulat, Moscow, Russia
[3] Ctr Rene Huguenin, St Cloud, France
关键词
D O I
10.1002/(SICI)1097-0215(19990909)82:6<822::AID-IJC9>3.0.CO;2-I
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Loss of heterozygosity (LOH) affects a number of chromosome regions in ovarian cancer, pointing to the possible involvement of tumour-suppressor genes in ovarian tumorigenesis. We performed comparative analysis of allelic loss at 6 frequently affected chromosome regions in a panel of 53 benign, borderline and malignant ovarian tumours. Precursor lesions could provide evidence that an accumulation of genetic events is required for normal ovarian epithelium to generate malignant tumours. LOH on chromosome Ip was relatively common in benign, borderline and malignant tumours, while at 11p and 7q it was observed not only in invasive but also in borderline tumours. Moreover, 17q and 18q were affected mainly in advanced malignant tumours and revealed a high frequency of clonal intratumoral heterogeneity. We encountered different spectra of genetic alterations in primary tumours and their metastasis, which may be the results of intratumoral heterogeneity leading to dissemination in only some sub-clones. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:822 / 826
页数:5
相关论文
共 50 条
  • [41] CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors
    Szymanska-Pasternak, J.
    Szymanska, A.
    Medrek, K.
    Imyanitov, E. N.
    Cybulski, C.
    Gorski, B.
    Magnowski, P.
    Dziuba, I.
    Gugala, K.
    Debniak, B.
    Gozdz, S.
    Sokolenko, A. P.
    Krylova, N. Y.
    Lobeiko, O. S.
    Narod, S. A.
    Lubinski, J.
    GYNECOLOGIC ONCOLOGY, 2006, 102 (03) : 429 - 431
  • [42] Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing
    Shibuya, Yusuke
    Tokunaga, Hideki
    Saito, Sakae
    Shimokawa, Kazurou
    Katsuoka, Fumiki
    Bin, Li
    Kojima, Kaname
    Nagasaki, Masao
    Yamamoto, Masayuki
    Yaegashi, Nobuo
    Yasuda, Jun
    GENES CHROMOSOMES & CANCER, 2018, 57 (02): : 51 - 60
  • [43] Alterations of HLA class I and class II antigen expressions in borderline, invasive and metastatic ovarian cancers
    Youn Soo Lee
    Tae Eung Kim
    Byung Kee Kim
    Yong Gyu Park
    Gyu-Moon Kim
    Sung-Bae Jee
    Ki Sung Ryu
    In-Kyung Kim
    Jin Woo Kim
    Experimental & Molecular Medicine, 2002, 34 : 18 - 26
  • [44] Alterations of HLA class I and class II antigen expressions in borderline, invasive and metastatic ovarian cancers
    Lee, YS
    Kim, TE
    Kim, BK
    Park, TG
    Kim, GM
    Jee, SB
    Ryu, KS
    Kim, IK
    Kim, JW
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2002, 34 (01): : 18 - 26
  • [45] Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas
    Österberg, Lovisa
    keson, Margaretha
    Levan, Kristina
    Partheen, Karolina
    Zetterqvist, Britt-Marie
    Brännström, Mats
    Horvath, György
    CANCER GENETICS AND CYTOGENETICS, 2006, 167 (02) : 103 - 108
  • [46] A case report of mucinous borderline ovarian tumor with recurrence as invasive carcinoma with high copy number alterations
    Wakazono, Emi
    Taki, Mana
    Watanabe, Koichi
    Yamanoi, Koji
    Murakami, Ryusuke
    Kakiuchi, Nobuyuki
    Yamaguchi, Ken
    Hamanishi, Junzo
    Minamiguchi, Sachiko
    Ogawa, Seishi
    Mandai, Masaki
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (04): : 520 - 524
  • [47] Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors
    Sieben, NLG
    Kolkman-Uljee, SM
    Flanagan, AM
    le Cessie, S
    Cleton-Jansen, AM
    Cornelisse, CJ
    Fleuren, GJ
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (04): : 1095 - 1101
  • [48] Differential expression of IL-8 and IL-8 receptors in benign, borderline and malignant ovarian epithelial tumours
    Browne, A.
    Sriraksa, R.
    Guney, T.
    Rama, N.
    Van Noorden, S.
    Curry, E.
    Gabra, H.
    Stronach, E.
    El-Bahrawy, M.
    CYTOKINE, 2013, 64 (01) : 413 - 421
  • [49] Primary Bone Tumours: Guiding Treatment Using Histology and Molecular Genetic Alterations
    Flanagan, A. M.
    JOURNAL OF PATHOLOGY, 2015, 237 : S4 - S4
  • [50] OPINION Non-genetic heterogeneity - a mutation-independent driving force for the somatic evolution of tumours
    Brock, Amy
    Chang, Hannah
    Huang, Sui
    NATURE REVIEWS GENETICS, 2009, 10 (05) : 336 - 342